Trial
NCT06008483
A Dose Finding Study to Treat Bone Tumor(s)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
QSAM Therapeutics, Inc.
Collaborators
—
Condition
Bone Cancer
Intervention
153-Sm-DOTMP (Samarium-153-DOTMP)
Why stopped
Change in development program indication
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-23